Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
24,183
Sort by:
Nasal Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit, Recombinant, and Conjugate Vaccines, Others), By Application (Influenza, COVID-19, Others (such as Cholera, Typhoid, etc.)), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Nasal Vaccines Market is projected to expand significantly, growing from USD 434.21 Million in 2025 to USD 623.29 Million by 2031, at a Compound Annual Growth Rate of 6.21%. These vaccines...
May 2026
180 pages
Oral Proteins & Peptides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Calcitonin, Insulin, Linaclotide, Octreotide, Plecanatide), By Application (Bone Diseases, Diabetes, Gastric & Digestive Disorders, Hormonal Disorders), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for oral proteins and peptides is projected to expand significantly, from USD 1.37 billion in 2025 to USD 2.36 billion by 2031, exhibiting a compound annual growth rate of 9.49%. The...
May 2026
185 pages
Pleurodynia Treatment Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Diagnosis (Blood test, Culture test, X-ray), By Treatment (Analgesics or Painkillers, Immunoglobulin), By Mode of Administration (Oral, Injections or infusion), By End-User (Hospitals, Pharmacy, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Pleurodynia Treatment Market is projected to expand from USD 152.11 Million in 2025 to USD 207.48 Million by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 5.31%. This market enco...
May 2026
180 pages
Pneumococcal Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Conjugate Vaccines, Polysaccharide Vaccines), By Indication (Bronchitis, Meningitis, Pneumonia, Sepsis), By Product (Pneumovax23, Prevnar 13, Synflorix), By Distribution (Government Authorities, Non-Governmental Organizations), By Region & Competition, 2021-2031F
US$ 4,500.00
The global pneumococcal vaccine market is projected to expand significantly, from USD 9.71 billion in 2025 to USD 13.98 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 6.26%. Th...
May 2026
185 pages
Pompe Disease Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, & Forecast, Segmented By Treatment Type (Drugs, Enzyme Replacement Therapy, Physical Therapy, Chaperone-Advanced Replacement Therapy), By Route of Administration (Oral, Parenteral), By End User (Hospitals & Speciality Clinics, Other), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Pompe Disease Therapeutics Market is projected to expand from USD 1.55 Billion in 2025 to USD 2.02 Billion by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 4.51%. This market pri...
May 2026
182 pages
Synthetic Hormones Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Amino Acid Derivatives, Peptide Hormone, Steroid Hormones), By Route of Administration (Intravenous, Nasal, Oral, Suppository, Topical), By Application (Growth Hormone Deficiency, Male Hypogonadism, Menopause, Thyroid Hormone Deficiency), By End User (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By Region, and Competition, 2021-2031F
US$ 4,500.00
The Global Synthetic Hormones Market is projected to expand significantly, growing from USD 619.12 Million in 2025 to USD 1242.47 Million by 2031, demonstrating a robust 12.31% Compound Annual Growth...
May 2026
177 pages
Vaccine Adjuvants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Adjuvant Emulsions, Pathogen Components, Saponin-Based Adjuvants, Particulate Adjuvants, Other Adjuvants), By Type (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), By Application (Research Applications, Commercial Applications), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Vaccine Adjuvants Market is projected to expand significantly, rising from USD 0.83 Billion in 2025 to USD 1.22 Billion by 2031, at a Compound Annual Growth Rate (CAGR) of 6.63%. Vaccine ad...
May 2026
180 pages
Global Microecological Drugs Market Growth 2026-2032
US$ 3,660.00
The global Microecological Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Microecological drugs refer t...
May 2026
147 pages
BCG Vaccines Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Immune BCG, Therapy BCG), By Application (Tuberculosis, Bladder Cancer), By Distribution Channel (Hospitals, Clinics, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global BCG Vaccines Market is projected to expand robustly, growing from USD 149.71 Million in 2025 to USD 212.01 Million by 2031, at a compound annual growth rate of 5.97%. The Bacillus Calmette-...
May 2026
180 pages
Clinical Trial Site Management Organization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Clinical Trial Services (Site Management, Project Management, Regulatory, Monitoring, Others), By Therapeutic Area (Oncology, Endocrinology Respiration, CNS, Pain Management, Endocrine, Others), By Phase (Phase I, Phase II, Phase III, Phase IV) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Clinical Trial Site Management Organization Market is projected to expand from USD 6.71 Billion in 2025 to USD 9.33 Billion by 2031, registering a CAGR of 5.65%. Functioning as essential in...
May 2026
192 pages
Genitourinary Drugs Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication (Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Urinary Incontinence & Overactive Bladder, Sexually Transmitted Diseases, Interstitial Cystitis, Hematuria, Benign Prostatic Hyperplasia), By Product (Hormonal Therapy, Gynecological, Urologicals, Anti-infectives, others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global genitourinary drugs market is anticipated to expand from USD 28.79 billion in 2025 to USD 33.56 billion by 2031, demonstrating a compound annual growth rate (CAGR) of 2.59%. This sector enc...
May 2026
180 pages
Graft Versus Host Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Acute Graft Versus Host Disease, Chronic Graft Versus Host Disease), By Product (Corticosteroids, Monoclonal Antibodies, Tyrosine Kinase Inhibitors), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Graft Versus Host Disease Treatment Market is projected to expand from USD 2.99 Billion in 2025 to USD 4.58 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 7.37%. This m...
May 2026
185 pages
H1N1 Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Route of Administration (Intradermal Vaccines, Intramuscular Vaccines, Intranasal Vaccines), By Type of Brand (Agripal, Fiuarix, Influgen, Influvac, Nasovac, Vaxigrip), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global H1N1 Vaccines Market is projected to expand from USD 10.13 billion in 2025 to USD 13.07 billion by 2031, demonstrating a compound annual growth rate of 4.34%. These vaccines, typically foun...
May 2026
185 pages
Omics-Based Clinical Trials Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Phase (Phase I, Phase II, Phase III, and Phase IV), By Study Design (Expanded Access Studies, Interventional Studies, and Observational Studies), By Indication (Cardiology, CNS Diseases, Genetic Diseases, Immunology, Oncology, Respiratory Diseases, and Skin Diseases), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Omics-Based Clinical Trials Market is projected to grow from USD 27.23 Billion in 2025 to USD 41.53 Billion by 2031, at a 7.29% CAGR. These trials leverage high-throughput technologies like...
May 2026
180 pages
Blind Loop Syndrome Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Tetracycline, Chlortetracycline, Oxytetracycline, Chloramphenicol), By Route of Administration (Injectable, Oral, Parenteral), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Blind Loop Syndrome Market is projected to expand from USD 13.22 Billion in 2025 to USD 18.17 Billion by 2031, registering a CAGR of 5.44%. Blind Loop Syndrome, frequently managed under the...
May 2026
180 pages
Castleman Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Multicentric Castlemans Disease, Unicentric Castlemans Disease), By Indication (Angiofollicular Lymph Node Hyperplasia, Angiomatous Lymphoid, Castleman Tumor, Giant Benign Lymphoma, Giant Lymph Node Hyperplasia, Hamartoma of the Lyphatics), By Therapy (Antiviral Drugs, Chemotherapy, Corticosteroids, Immunotherapy, Monoclonal Antibodies, Radiation Therapy), By End-user (Hospitals, Ambulatory Surgical Centers, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Castleman Disease Treatment Market is projected to expand from USD 0.28 Billion in 2025 to USD 0.52 Billion by 2031, registering a compound annual growth rate of 10.87%. This market sector...
May 2026
189 pages
Dermatology Contract Research Organization (CRO) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type ( Drug Discovery, Preclinical, Clinical), By Service Type (Laboratory, Technology, Medical Writing, Regulatory/Medical Affairs, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Dermatology Contract Research Organization (CRO) Market is projected to expand from USD 5.58 Billion in 2025 to USD 8.24 Billion by 2031, reflecting a CAGR of 6.71%. These specialized organ...
May 2026
180 pages
Hereditary Angioedema Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Other Drug Classes), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels), By Application (Prophylaxis, On-demand), By Region & Competition, 2021-2031F
US$ 4,500.00
The global Hereditary Angioedema (HAE) therapeutics market is projected to expand significantly, increasing from USD 4.41 billion in 2025 to USD 7.36 billion by 2031, demonstrating an 8.91% compound a...
May 2026
177 pages
IgA Nephropathy Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast Segmented By Test (Blood Test, Urine Test, Kidney Biopsy, Iothalamate Clearance Test, Others), By Treatment Type (Corticosteroids, Immunosuppressive Drugs, ACE Inhibitors And ARBs, Diet Change, Therapy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global IgA Nephropathy Disease Treatment Market is projected to expand from USD 173.75 Million in 2025 to USD 241.08 Million by 2031, achieving a compound annual growth rate of 5.61%. Treatment re...
May 2026
180 pages
Alport Syndrome Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Tablets, Capsules, Injectable, Others), By Disease Type (X-linked Alport Syndrome, Autosomal Recessive Alport Syndrome, Autosomal Dominant Alport Syndrome), By End User (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Alport Syndrome Treatment Market is projected to grow from USD 12.19 Million in 2025 to USD 16.82 Million by 2031, demonstrating a 5.51% CAGR. This market focuses on pharmacological therapi...
May 2026
180 pages
Central Fill Pharmacy Automation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product and Service (Equipment (Automated Medication Dispensing System, Integrated Workflow Automation Systems, Automated Packaging and Labeling Systems, Automated Tabletop Counters, Automated Medication Compounding Systems, Automated Storage and retrieval Systems, Other Automated Systems), Software, Services (Consulting, Workflow and process optimization, Facility Designing, Custom Software Development, Other)), By Vendor (Equipment Vendors, Consulting Vendors), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Central Fill Pharmacy Automation Market is projected to expand significantly, growing from USD 731.23 Million in 2025 to USD 1308.90 Million by 2031, reflecting a CAGR of 10.19%. This secto...
May 2026
180 pages
Anti Osteoporosis Therapy and Fracture Healing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Calcitonin, Bisphosphonates, Hormone Replacement Therapy, Anabolic, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-Commerce), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for anti-osteoporosis therapy and fracture healing is projected to expand significantly, rising from USD 15.34 billion in 2025 to USD 19.97 billion by 2031, at a compound annual grow...
May 2026
188 pages
Rare Hemophilia Factors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Factor Concentrates, Fresh Frozen Plasma, Cryoprecipitate, Others), By Type (Factor I, Factor II, Factor V, Factor VII, Factor X, Factor XI, Factor XIII) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Rare Hemophilia Factors Market is projected to expand significantly, growing from USD 345.11 million in 2025 to USD 506.69 million by 2031, at a compound annual growth rate (CAGR) of 6.61%....
May 2026
180 pages
Cannabidiol Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source Type (Hemp, Marijuana), By Sales Type (B2B, B2C), By End User (Medical {Chronic Pain, Mental Disorder, Cancer, Others}, Personal Use, Pharmaceuticals, Wellness {Food & Beverage, Personal Care & Cosmetics, Nutraceuticals, Others}), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cannabidiol Market is projected to expand from USD 6.88 Billion in 2025 to USD 14.07 Billion by 2031, reflecting a compound annual growth rate of 12.66%. Derived primarily from the Cannabis...
May 2026
185 pages
Cardiac Safety Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service (ECG/Holter Monitors, Blood Pressure Monitors, Cardiovascular Imaging, Others), By Type (Integrated and Standalone), By End Use (Pharma & Biopharma Companies, CROs, and Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cardiac Safety Services Market is projected to grow from USD 883.13 Million in 2025 to USD 1426.52 Million by 2031, at an 8.32% CAGR. These services involve specialized monitoring, collecti...
May 2026
185 pages
Liver Fibrosis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Interferon Therapy, Maloti Lipid, Nucleoside Analog), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for liver fibrosis drugs is projected to expand significantly, rising from USD 19.12 billion in 2025 to USD 33.91 billion by 2031, demonstrating a robust Compound Annual Growth Rate...
May 2026
180 pages
Peptides and Heparin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Peptides, Heparin), By Application (Oncology, Metabolic Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Anticoagulation Therapy, Others), By Route of Administration (Injectable, Oral, Others), By End User (Hospitals and Clinics, Research Institutes and Laboratories, Pharmaceutical and Biotechnology Companies, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for peptides and heparin is projected to expand significantly, rising from USD 13.41 billion in 2025 to USD 21.72 billion by 2031, reflecting an 8.37% compound annual growth rate. Pe...
May 2026
180 pages
Povidone Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By End-Use Application (Pharmaceutical, Food & Beverages, Personal Care & Cosmetics, Adhesives, and Others), By Sales Channel (Direct Sale, Indirect Sale), By Region & Competition, 2021-2031F
US$ 4,500.00
The global povidone market is projected to expand from USD 1.12 billion in 2025 to USD 1.55 billion by 2031, achieving a compound annual growth rate (CAGR) of 5.56%. Povidone, scientifically termed Po...
May 2026
180 pages
Sodium Ascorbate Excipient Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By End-Use Application (Pharmaceuticals, Food & Beverages, and Others), By Sales Channel (Direct Sale, Indirect Sale), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Sodium Ascorbate Excipient Market is projected to expand significantly, from USD 263.32 Million in 2025 to USD 443.32 Million by 2031, at a 9.07% compound annual growth rate. This critical...
May 2026
180 pages
Cholera Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Whole cell V. Cholerae O1 Recombinant With B-Subunit and Killed Oral O1 & O139), By Product (Vaxchora, Dukoral, Shanchol, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global cholera vaccines market is projected to expand significantly, growing from USD 97.32 Million in 2025 to USD 166.11 Million by 2031 at a 9.32% CAGR. These biological preparations, primarily...
May 2026
180 pages
Clavulanic Acid Series API Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Potassium Clavulanate, Amoxicillin & Potassium Clavulanate, Potassium Clavulanate with Avicel, Potassium Clavulanate with Silicon Dioxide), By Application (Oral Medications and Injectable Medications), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Clavulanic Acid Series API Market is projected to expand significantly, rising from USD 394.22 Million in 2025 to USD 587.32 Million by 2031, demonstrating a Compound Annual Growth Rate (CA...
May 2026
185 pages
Acute Pancreatitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Intravenous Fluid, Nutritional Support, Analgesics, Endoscopic Retrograde Cholangiopancreatography (ERCP), Other treatments), By Diagnosis (Imaging tests, Laboratory Tests), By End-User (Hospitals & Clinics, Ambulatory care Centers, Others) By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Acute Pancreatitis Market is projected to expand from USD 5.21 Billion in 2025 to USD 7.23 Billion by 2031, reflecting a compound annual growth rate (CAGR) of 5.61%. Acute pancreatitis, an...
May 2026
182 pages
Direct-acting Antiviral Drug Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (NS3/4A Protease, NS5A Protein, NS5B RNA-Dependent RNA polymerase), By Indication (Hepatitis C Virus, HIV Infection/ AIDS, Influenza, Prophylaxis), By Route (Intravenous, Oral, Subcutaneous, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Direct-acting Antiviral Drug Market is projected to expand significantly, growing from USD 11.91 Billion in 2025 to USD 23.71 Billion by 2031, demonstrating a robust CAGR of 12.16%. Direct-...
May 2026
180 pages
Lactose Intolerance Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Primary, Secondary, Congenital, Developmental), By Diagnosis (Hydrogen breath test, Glucose blood test, Stool acidity test), By Region & Competition, 2021-2031F
US$ 4,500.00
The global lactose intolerance market is projected to expand significantly, from USD 21.67 billion in 2025 to USD 32.14 billion by 2031, growing at a 6.79% CAGR. This market includes specifically form...
May 2026
188 pages
Marine Derived Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Ether, Peptide, Phenol, Steroid), By Source (Algae, Invertebrates, Microorganisms), By Application (Anti-Cardiovascular, Anti-Inflammatory, Anti-Microbial, Anti-Tumor, Anti-Viral), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Marine Derived Drugs Market is projected to expand significantly, from USD 13.02 billion in 2025 to USD 21.99 billion by 2031, demonstrating a compound annual growth rate of 9.13%. This mar...
May 2026
177 pages
Psychedelic Drug Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Drug Type (Lysergic Acid Diethylamide, Gamma Hydroxybutyric Acid, Ketamine, Psilocybin, Others), By Application (Treatment-Resistant Depression, Opiate Addiction, Post-Traumatic Stress Disorder, Narcolepsy, Panic Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Psychedelic Drug Market is projected to expand significantly, rising from USD 4.62 Billion in 2025 to USD 8.46 Billion by 2031, demonstrating a 10.61% compound annual growth rate. This mark...
May 2026
185 pages
Amphotericin B Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Systemic Fungal Infections, Candidiasis, Aspergillosis, Mucormycosis, Leishmaniasis, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Amphotericin B Market is forecast to grow from USD 561.05 Million in 2025 to USD 733.15 Million by 2031, exhibiting a 4.56% CAGR. Amphotericin B, a broad-spectrum polyene antifungal antibio...
May 2026
180 pages
Cefaclor Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Lung Infection, Skin Infection, Ear Infection, Throat Infection, Tonsils, Urinary Tract Infection, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global Cefaclor market is projected to expand from USD 352.67 million in 2025 to USD 440.35 million by 2031, exhibiting a compound annual growth rate (CAGR) of 3.77%. Cefaclor, a second-generation...
May 2026
180 pages
Cefpodoxime Proxetil Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Ear Infection, Nose Infection, Throat Infection, Lower Respiratory Tract Infection, Urinary Tract Infection, Skin Infection, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cefpodoxime Proxetil Market is projected to expand from USD 2.96 Billion in 2025 to USD 4.12 Billion by 2031, demonstrating a compound annual growth rate of 5.67%. Cefpodoxime Proxetil, an...
May 2026
180 pages
Cefuroxime Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By Grade (Axetil, Sodium), By End Use (Bronchitis, Gonorrhea, Lyme Disease, Skin Infection, Ear Infection, Throat Infection, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cefuroxime Market is projected to expand from USD 546.34 Million in 2025 to USD 746.49 Million by 2031, exhibiting a Compound Annual Growth Rate (CAGR) of 5.34%. This market revolves around...
May 2026
189 pages
Cephalexin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Urinary Tract Infection, Respiratory Infection, Otitis Media, Bone Infection, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Cephalexin Market is projected to expand from USD 389.03 Million in 2025 to USD 511.58 Million by 2031, reflecting a compound annual growth rate of 4.67%. Cephalexin, a first-generation cep...
May 2026
177 pages
Clarithromycin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Pneumonia, Bronchitis, Ear Infection, Skin Infection, Throat Infection, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Clarithromycin Market is projected to expand from USD 345.17 Million in 2025 to USD 423.07 Million by 2031, demonstrating a Compound Annual Growth Rate of 3.45%. This growth is underpinned...
May 2026
182 pages
Etoricoxib Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Osteoarthritis, Rheumatoid Arthritis, Ankylosing Spondylitis, Acute Gouty Arthritis, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global Etoricoxib market is projected to grow substantially from USD 123.21 Million in 2025 to USD 245.94 Million by 2031, demonstrating a 12.21% CAGR. Etoricoxib, a selective COX-2 inhibitor non-...
May 2026
182 pages
Fusidic Acid Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Impetigo, Cellulitis, Cuts & Wounds, Eye Infection, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global fusidic acid market is projected to expand from USD 31.12 million in 2025 to USD 35.27 million by 2031, at a CAGR of 2.11%. This bacteriostatic antibiotic, derived from Fusidium coccineum,...
May 2026
185 pages
Neomycin Sulphate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Skin Infection, Eye Infection, Ear Infection, Vaccine Production, Veterinary Medicine, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global Neomycin Sulphate market is projected to expand significantly, rising from USD 317.19 Million in 2025 to USD 453.77 Million by 2031, exhibiting a compound annual growth rate of 6.15%. Neomy...
May 2026
180 pages
Measles, Mumps, Rubella Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Monovalent, Trivalent (combined MMR), Tetravalent), By Targeted Population (Infants and children (9 months to 12), Adults), By Distribution Channel (Hospitals and Healthcare Institutions, Vaccine Centers and Public Health Clinics, Pediatric and Private Healthcare Clinics), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Measles, Mumps, Rubella (MMR) Vaccine Market is projected to expand significantly, rising from USD 2.19 Billion in 2025 to USD 3.65 Billion by 2031, demonstrating an 8.89% Compound Annual G...
May 2026
189 pages
Penicillin G Sodium Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Bacterial Infections, Syphilis, Prophylaxis, Meningitis, Combination Therapies, Others), By Region & Competition, 2021-2031F
US$ 4,500.00
The global market for Penicillin G Sodium, a narrow-spectrum beta-lactam antibiotic used intravenously or intramuscularly for severe bacterial infections such as syphilis, meningitis, and endocarditis...
May 2026
185 pages
Human Growth Hormone (HGH) Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Long Acting, Others), By Application (Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader-Willi Syndrome, Small for Gestational Age, Other), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Pharmacy), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global Human Growth Hormone (HGH) Market is on a robust growth trajectory, predicted to expand from USD 6.78 billion in 2025 to USD 14.82 billion by 2031, demonstrating a compound annual growth ra...
May 2026
185 pages
